CLEVELAND, April 22 /PRNewswire-FirstCall/ -- DATATRAK International, Inc. (Nasdaq: DATA), a technology and services company focused on global eClinical solutions for the clinical trials industry, today reported a multi-year agreement with the Portuguese CRO Keypoint - Consultoria cientifica, Lda. As the newest member of DATATRAK's CRO Connect Program(TM), Keypoint is able to expand its electronic data capture (EDC) capabilities and empower its staff to more efficiently manage both its paper and EDC studies.
"DATATRAK's eClinical(TM) is the platform that will give our customers a valuable solution on CDMS/EDC for clinical trials," said Keypoint CFO, Hugo Pedrosa. "We look at DATATRAK not only as a solution provider but as a partner who will bring added value to our services."
"We welcome Keypoint as the newest member of the CRO Connect Program(TM)," said DATATRAK CEO, Larry Birch. "Keypoint joins a growing list of CROs who are benefiting from our DATATRAK eClinical(TM) platform, specialized pricing and joint marketing of the CRO Connect Program. We look forward to supporting Keypoint as they broaden their service offering and develop new revenue streams utilizing our platform."
DATATRAK's CRO Connect Program is a collaborative initiative with CROs that offers the benefits of our comprehensive DATATRAK eClinical(TM) solution through an innovative Enterprise Transfer program. This program allows CROs to package their services around our eClinical(TM) platform in order to gain efficiencies and increased market share. The CRO Connect Program's flexible pricing and specialized consulting and professional services provides participants with the tools necessary to realize new growth opportunities.
Keypoint is a Portuguese CRO who specializes in observational studies. To date, Keypo
|SOURCE DATATRAK International, Inc.|
Copyright©2009 PR Newswire.
All rights reserved